Siemens Fonds Invest GmbH purchased a new stake in The Cooper Companies, Inc. (NYSE:COO – Get Rating) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 675 shares of the medical device company’s stock, valued at approximately $223,000.
Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Silvercrest Asset Management Group LLC raised its position in Cooper Companies by 104.6% in the 4th quarter. Silvercrest Asset Management Group LLC now owns 6,186 shares of the medical device company’s stock valued at $2,046,000 after purchasing an additional 3,163 shares during the last quarter. Quantinno Capital Management LP increased its position in Cooper Companies by 1,020.9% in the 4th quarter. Quantinno Capital Management LP now owns 10,514 shares of the medical device company’s stock valued at $3,477,000 after acquiring an additional 9,576 shares during the period. Townsquare Capital LLC increased its position in Cooper Companies by 15.4% in the 4th quarter. Townsquare Capital LLC now owns 16,600 shares of the medical device company’s stock valued at $5,489,000 after acquiring an additional 2,210 shares during the period. First Republic Investment Management Inc. increased its position in Cooper Companies by 23.4% in the 4th quarter. First Republic Investment Management Inc. now owns 2,310 shares of the medical device company’s stock valued at $764,000 after acquiring an additional 438 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its position in Cooper Companies by 3.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 268,550 shares of the medical device company’s stock valued at $88,801,000 after buying an additional 8,840 shares during the last quarter. Hedge funds and other institutional investors own 96.78% of the company’s stock.
Insider Buying and Selling at Cooper Companies
In other news, CAO Agostino Ricupati sold 1,000 shares of the business’s stock in a transaction on Friday, March 31st. The stock was sold at an average price of $370.00, for a total value of $370,000.00. Following the completion of the transaction, the chief accounting officer now directly owns 863 shares of the company’s stock, valued at $319,310. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 2.00% of the company’s stock.
Analysts Set New Price Targets
Cooper Companies Stock Up 2.8 %
Cooper Companies stock opened at $355.95 on Tuesday. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.95 and a current ratio of 1.69. The firm has a market capitalization of $17.62 billion, a price-to-earnings ratio of 61.37, a price-to-earnings-growth ratio of 2.46 and a beta of 0.92. The Cooper Companies, Inc. has a fifty-two week low of $244.21 and a fifty-two week high of $395.20. The stock’s fifty day moving average is $375.83 and its two-hundred day moving average is $351.24.
Cooper Companies (NYSE:COO – Get Rating) last posted its earnings results on Thursday, June 1st. The medical device company reported $3.08 earnings per share for the quarter, beating the consensus estimate of $3.04 by $0.04. The company had revenue of $877.40 million for the quarter, compared to analyst estimates of $865.81 million. Cooper Companies had a return on equity of 8.18% and a net margin of 8.41%. Cooper Companies’s revenue was up 5.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $3.24 earnings per share. Analysts predict that The Cooper Companies, Inc. will post 12.8 EPS for the current fiscal year.
Cooper Companies Profile
The Cooper Cos, Inc operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues.
Featured Articles
- Get a free copy of the StockNews.com research report on Cooper Companies (COO)
- Can Cardinal Health Fly Higher In 2023?
- DraftKings Stock, Is There Royally Good Upside Ahead?
- Disney Stock Could Double: Return To Historical Performance
- For AI Exposure, Try Global Artificial Intelligence ETF
- 3 Penny Stocks The Insiders Are BuyingÂ
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.